Related Experiment Video

Updated: Jul 15, 2026

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat (VNTR) - Fragment Length Analysis (FLA)
09:39

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat (VNTR) - Fragment Length Analysis (FLA)

Published on: July 15, 2011

Mycobacterial infections: PARK2 and PACRG associations in leprosy

E Schurr1, A Alcais, M Singh

  • 1Montreal General Hospital Research Institute, McGill Center for the Study of Host Resistance, Montreal, PQ, Canada. erwin.schurr@mcgill.ca

Tissue Antigens
|April 21, 2007
PubMed

Insights

Host genetics significantly influence leprosy susceptibility and progression. Investigations highlight the critical roles of both major histocompatibility complex (MHC) and non-MHC genes in the disease.

Area of Science:

  • Immunogenetics
  • Infectious Diseases
  • Human Genetics

Background:

  • Leprosy is a complex infectious disease with significant variability in clinical presentation and outcome.
  • The influence of host genetic factors on leprosy susceptibility and pathogenesis is increasingly recognized.

Purpose of the Study:

  • To provide a comprehensive overview of current research on the role of host genetics in leprosy.
  • To highlight the contributions of both major histocompatibility complex (MHC) and non-MHC genetic loci.

Main Methods:

  • Review of published scientific literature and genetic association studies.
  • Analysis of data from various populations regarding genetic markers and leprosy.

Main Results:

  • Genetic variations within the major histocompatibility complex (MHC) region are strongly associated with leprosy.
  • Numerous non-MHC genes have also been identified as significant contributors to leprosy susceptibility and immune response.

Conclusions:

  • Host genetics play a pivotal role in determining an individual's risk and disease course in leprosy.
  • Understanding these genetic factors is crucial for developing targeted prevention and treatment strategies.

More Related Videos

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice10:32

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice

Published on: March 23, 2014

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...